Ingevity (FRA:IGX) Long-Term Debt: €936 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:IGX Ingevity Corp FRA:IGX
62 GF Score
Price €63.50
GF Value €36.94
! 6 Warning Signs
View Full Analysis

What is Ingevity Long-Term Debt?

Ingevity FRA:IGX +2.42% 62 Long-Term Debt is €936 Mil as of Mar. 2026. GuruFocus rates FRA:IGX with a GF Score™ of 62/100 and a GF Value™ of €36.94. The stock has 6 warning signs investors should review.

Ingevity's Long-Term Debt for the quarter that ended in Mar. 2026 was €936 Mil.

Ingevity's quarterly Long-Term Debt increased from Sep. 2025 (€987 Mil) to Dec. 2025 (€992 Mil) but then declined from Dec. 2025 (€992 Mil) to Mar. 2026 (€936 Mil).

Ingevity's annual Long-Term Debt increased from Dec. 2023 (€1,268 Mil) to Dec. 2024 (€1,279 Mil) but then declined from Dec. 2024 (€1,279 Mil) to Dec. 2025 (€992 Mil).

Ingevity  (FRA:IGX) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Ingevity Long-Term Debt Related Terms

Ingevity Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Ingevity's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ingevity Long-Term Debt Chart

Ingevity Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,106.25 1,390.04 1,268.03 1,279.41 991.84

Ingevity Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,232.66 1,071.27 987.04 991.84 936.28
FRA:IGX
62GF Score
Ingevity Corp FRA:IGX
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €936 Mil mean?
Ingevity (FRA:IGX) has a Long-Term Debt of €936 Mil as of Mar. 2026.
Is Ingevity's Long-Term Debt too high?
Ingevity's current Long-Term Debt is €936 Mil. Overall, Ingevity has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Ingevity's Long-Term Debt compare to KWR and MTX?
Ingevity's Long-Term Debt of €936 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Chemicals company?
A good Long-Term Debt depends on the Chemicals industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Ingevity's current Long-Term Debt is €936 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ingevity stock overvalued right now?
Ingevity (FRA:IGX) has a current Long-Term Debt of €936 Mil. The stock's GF Value™ is €36.94, compared to a current price of €63.50 — trading 71.9% above its estimated fair value. The current Long-Term Debt is €936 Mil. Ingevity's overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Ingevity (FRA:IGX), the current Long-Term Debt is €936 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ingevity (FRA:IGX) Overvalued in 2026?

Based on GuruFocus' analysis, Ingevity stock appears to be overvalued. The current stock price of €63.50 is trading 71.9% above its estimated GF Value™ of €36.94.

Key valuation signals for FRA:IGX:

  • Long-Term Debt: €936 Mil
  • GF Value™: €36.94 vs. price of €63.50 (71.9% above fair value)
  • GF Score™: 62/100 with 6 warning signs

No single metric tells the full story. See the FRA:IGX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ingevity Business Description

Other Exchanges NGVT:USAIGX:Germany
Address 4920 O\'Hear Avenue, Suite 400, North Charleston, SC, USA, 29405
Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The company generates the majority of its revenue from North America.
62GF Score

Get the complete analysis for FRA:IGX

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€63.50
Price
€36.94
GF Value